Table 2:
The summary of comparison of HPLC, Florescence AGE assay and Raman parameters across glucose-incubated groups. Significant p-values are in bold. N.S.: not significant.
| Parameters | Glycation Treatment | |||||||
|---|---|---|---|---|---|---|---|---|
| Glucose | ||||||||
| G-Control | G-0.1 M | G-0.5 M | G-Control vs. G-0.1 M | G-Control vs. G-0.5 M | G-0.1 M vs. G-0.5 M | |||
| HPLC Parameters |
PEN/collagen | mol/mol of collagen | 2.9±1.1 | 3.1±1.1 | 4.2±1.2 | N.S. | p=0.010 | p=0.011 |
| DPD/collagen | mol/mol of collagen | 0.241±0.052 | 0.226±0.071 | 0.217±0.056 | N.S. | N.S. | N.S. | |
| PYD/collagen | mol/mol of collagen | 0.423±0.090 | 0.398±0.088 | 0.408±0.091 | N.S. | N.S. | N.S. | |
| Fluorescence AGE Assay | fAGEs | g/mol | 64.4±27.9 | 96.9±83.3 | 101.3±73.3 | N.S. | N.S. | N.S. |
| Raman Parameters | Mineral-to-Matrix | ν1PO4/Amide I | 27.63±2.03 | 28.07±2.74 | 26.52±2.37 | N.S. | N.S. | N.S. |
| ν1PO4/Amide III | 13.64±0.74 | 13.88±1.02 | 13.98±0.74 | N.S. | N.S. | N.S. | ||
| ν1PO4/CH2 wag | 13.26±0.64 | 13.43±1.00 | 13.59±0.89 | N.S. | N.S. | N.S. | ||
| ν1PO4/Proline | 17.67±1.03 | 17.41±0.50 | 16.99±0.81 | N.S. | N.S. | N.S. | ||
| Carbonate Substitution | CO3/ν1PO4 | 0.138±0.005 | 0.139±0.006 | 0.142±0.005 | N.S. | N.S. | N.S. | |
| Crystallinity | 1/FWHM(ν1PO4) | 0.066±0.003 | 0.065±0.001 | 0.064±0.001 | N.S. | N.S. | N.S. | |
| Hyp/Pro | 877/855 | 0.73±0.01 | 0.75±0.02 | 0.76±0.02 | N.S. | p=0.0069 | N.S. | |
| 877/922 | 0.68±0.02 | 0.72±0.01 | 0.75±0.04 | N.S. | p=0.0039 | N.S. | ||
| Raman-PEN | ~1362/CH2-wag | 0.335±0.016 | 0.331±0.037 | 0.295±0.049 | N.S. | N.S. | N.S. | |
| ~1495/CH2-wag | 0.077±0.008 | 0.077±0.015 | 0.070±0.014 | N.S. | N.S. | N.S. | ||
| Raman-CML | ~1150/CH2-wag | 0.030±0.005 | 0.031±0.009 | 0.027±0.010 | N.S. | N.S. | N.S. | |